Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Norak brings in $13mm in Series B round

Executive Summary

Norak Biosciences (develops drugs that regulate G protein-coupled receptors--GPCRs) completed a Series B financing, bringing in $13mm. New investors included Noro-Moseley Partners (which led the round), Mitsui & Co. Venture Partners, Alexandria Real Estate Equities, and Koch Enterprises. Also participating were return investors Intersouth Partners and Aurora Funds.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies